Answers are grounded in this paper and cite their sources.
Commentary observes widespread awareness of GLP-1 agonists among older demographics, highlighting the impact of pervasive direct-to-consumer advertising.
A couple of years ago, I started exercising at home instead of going to the local Y. I'd typically have a television cable news channel on to keep me company, and was thereby subjected to abundant commercial advertising. Aside from marveling at the remarkably precise targeting of my demographic (old people), I pretty much managed to tune out the content. Recently, however, during more purposeful encounters with the media, I have found myself inundated with discussions of a specific product I had previously only associated with a strikingly annoying jingle: Ozempic.
No takes yet. Share an insight, caveat, or question.
Lawrence H. Price (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: